And interference of POLD2 with shRNA inhibited glioblastoma cell proliferation, cell cycle progression, invasiveness, and sensitized glioblastoma cells to chemo/radiation-induced cell death, indicating that POLD2 is a new potential therapeutic target for glioblastoma (11). Here, POLD2 is linked to glioblastoma.